Crohn's Disease (Regional Enteritis) Global Clinical Trials Market Review 2025: G7 And E7 Activities, Trial Status, Sponsor Insights, Enrollment Trends, Company Listings, Unaccomplished Trials

(MENAFN- GlobeNewsWire - Nasdaq) The report highlights strategic insights into global Crohn's Disease clinical trials, emphasizing opportunities for investment and cost-efficient trial locations. It aids in formulating business strategies, understanding trends, and assessing trial success rates, thereby enhancing competitive advantage in the clinical trial market.

Dublin, Feb. 05, 2026 (GLOBE NEWSWIRE) -- The "Crohn's Disease (Regional Enteritis) - Global Clinical Trials Review, 2025" clinical trials has been added to ResearchAndMarkets's offering.
This report provides top line data relating to the clinical trials on Crohn's Disease (Regional Enteritis). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.

Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). The analyst Clinical Trial Reports are generated using the analyst's proprietary database - Pharma - Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.
The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.
Report Scope

• The report provides a snapshot of the global clinical trials landscape
• Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
• The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
• The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
• The Report provides enrollment trends for the past five years
• Report provides latest news for the past three months

Latest Clinical Trials News on Crohn's Disease (Regional Enteritis)

• Dec 03, 2025: Onco3R Therapeutics Announces Completion of First Multiple Ascending Dose Cohort in Phase 1 Trial of Novel SIK3 Inhibitor O3R-5671
• Nov 17, 2025: Agomab Announces Positive Topline Phase 2a Data for Ontunisertib in Fibrostenosing Crohn's Disease
• Oct 29, 2025: Avobis Presents Results from the Randomized Multicenter STOMP2 Clinical Trial at a Plenary Session of the ACG's Annual Scientific Meeting
• Oct 28, 2025: Sitryx Presents New Preclinical Data Highlighting MTHFD2 as a Novel Metabolic Target in Autoimmune Disease at ACR Convergence 2025
• Oct 27, 2025: TREMFYA, first and only IL-23 inhibitor with a fully subcutaneous treatment regimen, demonstrates durable remission in Crohn's disease at two years
• Oct 24, 2025: Tremfya Receives EC Approval for SC Through to Maintenance in Adults With UC, Now the First Il-23 Inhibitor With a Fully Subcutaneous Dose Regimen
• Oct 20, 2025: Palisade Bio Announces First Patients Dosed in Phase 1b Study of Oral First-In-Class PDE4 Inhibitor Prodrug, PALI-2108, for the Treatment of FSCD
• Oct 06, 2025: Merck Expands Tulisokibart Clinical Development Program With Initiation of Phase 2b Trials in Three Additional Immune-Mediated Inflammatory Diseases
• Oct 06, 2025: Onco3R Therapeutics Announces Completion of First Cohort in Phase 1 Trial of Novel SIK3 inhibitor O3R-5671 and Oral Presentation at UEGW 2025

Companies Featured

• AbbVie Inc
• Takeda Pharmaceutical Co Ltd
• Johnson & Johnson
• Pfizer Inc
• Thermo Fisher Scientific Inc
• Labcorp Holdings Inc
• UCB SA
• The Alimentiv Health Trust
• ICON Plc
• IQVIA Holdings Inc

Key Topics Covered:

• Report Guidance
• The analyst Clinical Trials Report Coverage
• Clinical Trials by Region
• Clinical Trials and Average Enrollment by Country
• Top Five Countries Contributing to Clinical Trials in Asia-Pacific
• Top Five Countries Contributing to Clinical Trials in Europe
• Top Countries Contributing to Clinical Trials in North America
• Top Five Countries Contributing to Clinical Trials in Middle East and Africa
• Top Five Countries Contributing to Clinical Trials in Central and South America
• Clinical Trials by G7 Countries: Proportion of Crohn's Disease (Regional Enteritis) to Gastrointestinal Clinical Trials
• Clinical Trials by Phase in G7 Countries
• Clinical Trials in G7 Countries by Trial Status
• Clinical Trials by E7 Countries: Proportion of Crohn's Disease (Regional Enteritis) to Gastrointestinal Clinical Trials
• Clinical Trials by Phase in E7 Countries
• Clinical Trials in E7 Countries by Trial Status
• Clinical Trials by Phase
• In Progress Trials by Phase
• Clinical Trials by Trial Status
• Clinical Trials by End Point Status
• Subjects Recruited Over a Period of Time
• Clinical Trials by Sponsor Type
• Prominent Sponsors
• Top Companies Participating in Crohn's Disease (Regional Enteritis) Therapeutics Clinical Trials
• Prominent Drugs
• Clinical Trial Profile Snapshots
• Appendix

For more information about this clinical trials report visit

About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

CONTACT: CONTACT: Laura Wood,Senior Press Manager... For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900

MENAFN05022026004107003653ID1110700222